½ÃÀ庸°í¼­
»óǰÄÚµå
1271297

¼¼°èÀÇ ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ÏÃæ¾× ¼ººÐº°, ¿ÏÃæ¾× Á¦Á¶ ¹æ¹ýº°, Àç·á Çüź°, Áö¿ªº° - ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2023-2030³â)

Biopharma Buffer Market, By Type, By Application, By End User, By Buffer Component, By Buffer Preparation, By Material Form, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾×Àº ´ÜŬ·Ð Ç×ü, À¯ÀüÀÚ Ä¡·á, ¹é½Å, źÁ¨¼È ÇÃ·Î¿ì ¿©°ú °øÁ¤ µî ¸¹Àº ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶ °øÁ¤¿¡ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°¿¡ Æ÷ÇÔµÈ È­ÇÐ ¼ººÐÀº pH º¯È­¿¡ ¹Î°¨Çϱ⠶§¹®¿¡ pH¸¦ ƯÁ¤ ¹üÀ§·Î À¯ÁöÇϱâ À§ÇØ ¿ÏÃæ¾×ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¿ÏÃæ¾×¿¡´Â »ê ¶Ç´Â ¿°±â Á¢ÇÕü°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. °ø¾× »êÀº 󸮵Ǵ Á¦Ç°ÀÇ À¯Çü¿Í Á¦Á¶ °øÁ¤¿¡ µû¶ó ¼±Åõ˴ϴÙ. ÀϹÝÀûÀ¸·Î ÀÌ·¯ÇÑ ¿ë¾×ÀÇ ¾ÈÁ¤µÈ pH´Â 7.0-10.0ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°è ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ´Ù¿î½ºÆ®¸² ó¸® ÀåºñÀÇ ¼¼Ã´ ¹× ¼Òµ¶À» À§ÇÑ ¼ö¿ë¾×¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁú °áÁ¤È­ ¹× ¼¼Æ÷ ¹è¾ç ±â¼ú¿¡ ´ëÇÑ ¿¬±¸ Ȱµ¿ Áõ°¡, ½Å¾à °³¹ß ¹× °³¹ß °úÁ¤¿¡¼­ ¿ÏÃæ¾× »ç¿ëÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ¿ÏÃæ¾× Á¦Á¶¿¡ µû¸¥ º¹À⼺ÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð¿Í CAGRÀ» Á¦½ÃÇÏ´Â ¼¼°è ¹ÙÀÌ¿ÀÆÄ¸¶ ¹öÆÛ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ¿´½À´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¶Ç´Â ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª Àü¸Á ¹× ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·«¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×À» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µî ´ÙÀ½°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæÁ¦ ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ °³¿ä
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
    • ½ÃÀå ÇöȲ : À¯Çüº°
    • ½ÃÀå ÇöȲ : ¿ëµµº°
    • ½ÃÀå ÇöȲ : ÃÖÁ¾»ç¿ëÀÚº°
    • ½ÃÀå ÇöȲ : ¹öÆÛ ÄÄÆ÷³ÍÆ®º°
    • ½ÃÀå ÇöȲ : ¹öÆÛ Á¶Á¦¹°º°
    • ½ÃÀå ÇöȲ : Àç·á Çüź°
    • ½ÃÀå ÇöȲ : Áö¿ªº°
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À

Á¦4Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ Á¶»ç
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå, À¯Çüº°, 2017³â-2030³â

  • Pre-formulated buffers
  • Customized buffers
  • Concentrated buffers
  • ±âŸ

Á¦6Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå, ¿ëµµº°, 2017-2030³â

  • ¼¼Æ÷¹è¾ç
  • Á¤Á¦
  • Á¦Á¦È­

Á¦7Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2017³â-2030³â

  • ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷
  • ¼öŹ¿¬±¸±â°ü
  • Çмú±â°ü ¹× ¿¬±¸±â°ü

Á¦8Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå : ¹öÆÛ ¼ººÐº°, 2017³â-2030³â

  • ¾Æ¹Ì³ë»ê
  • ¾Æ¼¼Æ®»ê
  • Àλê
  • È÷½ºÆ¼µò
  • ±âŸ

Á¦9Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå, ¹öÆÛ Á¶Á¦¹ýº°, 2017-2030³â

  • ¾×»ó
  • ºÐ¸»

Á¦10Àå ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå : Àç·á Çüź°, 2017³â-2030³â

  • °Ç½Ä
  • ¾×»ó

Á¦11Àå : ¹ÙÀÌ¿ÀÁ¦¾à ¿ÏÃæ¾× ½ÃÀå : Áö¿ªº°, 2017³â-2030³â

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå °æÀï ±¸µµ

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Avantor, Inc.
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • Sartorius AG
  • Corning Inc.
  • Becton, Dickinson and Company
  • GE Healthcare
  • Promega Corporation

Á¦13Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý¿¡ ´ëÇØ
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 23.05.26

Biological buffers are used in a number of biopharmaceutical manufacturing processes, including monoclonal antibody, gene therapy, vaccine, and tangential flow filtration steps. The chemical components found in these products are sensitive to changes in pH, and thus require buffers to keep the pH within a specified range. Buffers are formulated with either a conjugate acid or base. The conjugate is chosen based on the type of product to be processed and the process steps that will be performed during its preparation. Typically, these solutions have a stable pH of between 7.0 and 10.0.

Market Dynamics:

The global biopharma buffer market is expected to grow at a high growth rate during the forecast period. The major drivers for this market are increasing demand for aqueous solutions for cleaning and disinfecting downstream processing equipment. Moreover, growing research activities related to protein crystallization and cell culture techniques and the use of buffers in drug discovery and development processes are other factors propelling market growth.

However, complexity associated with the preparation of buffer is expected to hamper the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global biopharma buffer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biopharma buffer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Avantor, Inc., Lonza Group Ltd., Bio-Rad Laboratories, Inc., Sartorius AG, Corning Inc., Becton, Dickinson and Company, GE Healthcare, and Promega Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biopharma buffer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharma buffer market

Detailed Segmentation:

  • Global Biopharma Buffer Market, By Type:
    • Pre-formulated buffers
    • Customized buffers
    • Concentrated buffers
    • Others
  • Global Biopharma Buffer Market, By Application:
    • Cell Culture
    • Purification
    • Formulation
  • Global Biopharma Buffer Market, By End User:
    • Biopharmaceutical Companies
    • Contract Research Organizations
    • Academic & Research Institutes
  • Global Biopharma Buffer Market, By Buffer Component:
    • Amino acids
    • Acetic acid
    • Phosphate
    • Histidine
    • Others
  • Global Biopharma Buffer Market, By Buffer Preparation:
    • Liquid
    • Powder
  • Global Biopharma Buffer Market, By Material Form:
    • Dry
    • Liquid
  • Global Biopharma Buffer Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Avantor, Inc.
    • Lonza Group Ltd.
    • Bio-Rad Laboratories, Inc.
    • Sartorius AG
    • Corning Inc.
    • Becton, Dickinson and Company
    • GE Healthcare
    • Promega Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Buffer Component
    • Market Snapshot, By Buffer Preparation
    • Market Snapshot, By Material Form
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for aqueous solutions for cleaning and disinfecting process
  • Evolving biopharmaceutical industry
    • Restraints
  • Issues associated with the preparation of buffer
    • Opportunities
  • Growing research activities related to protein crystallization and cell culture techniques
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biopharma Buffer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biopharma Buffer Market , By Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Pre-formulated buffers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Customized buffers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Concentrated buffers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Biopharma Buffer Market , By Application, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Cell Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Purification
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Formulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Biopharma Buffer Market , By End User, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Biopharma Buffer Market , By Buffer Component, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Amino acids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Acetic acid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Phosphate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Histidine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

9. Global Biopharma Buffer Market , By Buffer Preparation, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

10. Global Biopharma Buffer Market , By Material Form, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Dry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

11. Global Biopharma Buffer Market , By Region, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2023 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Component, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Preparation, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Form, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Component, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Preparation, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Form, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Component, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Preparation, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Form, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Component, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Preparation, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Form, 2017-2030,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Component, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Buffer Preparation, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Form, 2017-2030,(US$ Mn)

12. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
  • Avantor, Inc.
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • Sartorius AG
  • Corning Inc.
  • Becton, Dickinson and Company
  • GE Healthcare
  • Promega Corporation

13. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦